Rho Capital Partners

Latest statistics and disclosures from RHO CAPITAL PARTNERS's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Anacor Pharmaceuticals In, IL, Everyday Health, Cara Therapeutics, Inotek Pharmaceuticals. These five stock positions account for 90.55% of RHO CAPITAL PARTNERS's total stock portfolio.
  • Added to shares of these 1 stocks: Rubicon Proj (+$11.94M).
  • Started 1 new stock positions in Rubicon Proj.
  • As of June 30, 2015, RHO CAPITAL PARTNERS has $286.00M in assets under management (AUM). Assets under management grew from a total value of $239.85M to $286.00M.
  • Independent of market fluctuations, RHO CAPITAL PARTNERS was a net buyer by $11.94M worth of stocks in the most recent quarter.

RHO CAPITAL PARTNERS portfolio companies for June 2015 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
Anacor Pharmaceuticals In 28.91 1067892 77.43 0.00
IL IntraLinks Holdings 27.03 6490503 11.91 10.29
Everyday Health 18.35 4107522 12.78 0.00
Cara Therapeutics 11.33 2668057 12.15 0.00
Inotek Pharmaceuticals 4.92 2870584 4.90 0.00
Rubicon Proj 4.18 NEW 798381 14.96 0.00
RLOC ReachLocal 2.83 2570395 3.15 3.08
Nephrogenex 2.44 1052966 6.64 0.00

Past 13F-HR SEC Filings for RHO CAPITAL PARTNERS

View All Filings for RHO CAPITAL PARTNERS